Terms: = Lymphoma AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Prognosis
94 results:
1. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
[TBL] [Abstract] [Full Text] [Related]
2. [Successful treatment with tucidinostat in a patient with relapsed adult T-cell leukemia/lymphoma following allogeneic hematopoietic stem cell transplantation].
Moriki A; Ito S; Horikita F; Tsutsumi Y
Rinsho Ketsueki; 2024; 65(1):18-23. PubMed ID: 38311384
[TBL] [Abstract] [Full Text] [Related]
3. Characteristics and therapeutic approaches for patients diagnosed with T-ALL/LBL exhibiting t(8;14)(q24;q11)/TCRA/D:MYC translocation.
Zhang X; Wang T; Zhang Y; Wang F; Chen J; Ni J; Sun R; Wei Z; Zhang G; Li W; Li J; Lu P
Leuk Lymphoma; 2023 Dec; 64(13):2133-2139. PubMed ID: 37674391
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapy.
Shirouchi Y; Nishimura N; Mishima Y; Ishihara Y; Asai H; Tamba M; Hirano M; Hirano K; Teramoto Y; Yoshida K; Takeuchi K; Terauchi T; Maruyama D
Sci Rep; 2023 Aug; 13(1):13713. PubMed ID: 37608029
[TBL] [Abstract] [Full Text] [Related]
5. Real-world data from yttrium-90 ibritumomab tiuxetan treatment of relapsed or refractory indolent B-cell non-Hodgkin's lymphoma: J3Zi Study.
Choi I; Okada M; Ito T
Ann Hematol; 2023 May; 102(5):1149-1158. PubMed ID: 36995403
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical features of 19 patients with sil-TAL1-positive T-cell acute lymphoblastic leukemia].
Wang LJ; Chen Y; Xiang M; Yang XF; Chen SN
Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):132-136. PubMed ID: 36948867
[No Abstract] [Full Text] [Related]
7. [Detection of Fusion Gene and prognosis Analysis in Children with Acute Lymphoblastic Leukemia of Different Immunophenotypes].
Liu CY; Pan YS; Yang H; Hu X; Chen HY; Liu WJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1673-1678. PubMed ID: 36476888
[TBL] [Abstract] [Full Text] [Related]
8. Serum cell-free DNA concentration as a possible prognostic marker in newly diagnosed diffuse large B-cell lymphoma.
Shirouchi Y; Mishima Y; Takayama T; Minowa S; Ishihara Y; Tamba M; Hirano M; Onda N; Takeuchi K; Maruyama D
Biomed Res; 2022; 43(4):99-106. PubMed ID: 35989290
[TBL] [Abstract] [Full Text] [Related]
9. Sequential Approach to Improve the Molecular Classification of Childhood Acute Lymphoblastic Leukemia.
Yu CH; Wu G; Chang CC; Jou ST; Lu MY; Lin KH; Chen SH; Wu KH; Huang FL; Cheng CN; Chang HH; Hedges D; Wang JL; Yen HJ; Li MJ; Chou SW; Hung CT; Lin ZS; Lin CY; Chen HY; Ni YL; Hsu YC; Lin DT; Lin SW; Yang JJ; Pui CH; Yu SL; Yang YL
J Mol Diagn; 2022 Nov; 24(11):1195-1206. PubMed ID: 35963521
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.
Kumari S; Ali MS; Singh J; Arora M; Verma D; Pandey AK; Benjamin M; Bakhshi S; Palanichamy JK; Sharma A; Singh I; Tanwar P; Singh AR; Pushpam D; Qamar I; Chopra A
Hematol Oncol; 2022 Oct; 40(4):577-587. PubMed ID: 35644022
[TBL] [Abstract] [Full Text] [Related]
11. prognosis of Indolent Adult T-Cell Leukemia/lymphoma.
Kameda T; Shide K; Tahira Y; Sekine M; Sato S; Ishizaki J; Takeuchi M; Akizuki K; Kamiunten A; Shimoda H; Toyama T; Maeda K; Yamashita K; Kawano N; Kawano H; Hidaka T; Yamaguchi H; Kubuki Y; Kitanaka A; Matsuoka H; Shimoda K
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458440
[TBL] [Abstract] [Full Text] [Related]
12. Relationship between the absolute lymphocyte count/absolute monocyte count ratio, soluble interleukin 2 receptor level, serum programmed cell death 1 level, and the prognosis of patients with diffuse large B-cell lymphoma.
Li C; Li W; Xu G; You M; Wu W; Kuang L
Ann Palliat Med; 2021 Oct; 10(10):10938-10945. PubMed ID: 34763456
[TBL] [Abstract] [Full Text] [Related]
13. CARMA1 is required for Notch1-induced NF-κB activation in sil-TAL1-negative T cell acute lymphoblastic leukemia.
Zhang N; Xu J; Wang R; Pan T; Zhang H; Yin L; Yao Y; Xu L; Zhu S; Wu Q; Li Z; Liu X; Xu K; Niu M
J Mol Med (Berl); 2021 Oct; 99(10):1447-1458. PubMed ID: 34223928
[TBL] [Abstract] [Full Text] [Related]
14. Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report.
Ishiguro K; Sasaki Y; Takagi Y; Niinuma T; Suzuki H; Tokino T; Hayashi T; Takahashi T; Igarashi T; Matsuno Y
Medicine (Baltimore); 2020 Aug; 99(35):e21938. PubMed ID: 32871937
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathological analysis of 34 Japanese patients with EBV-positive mucocutaneous ulcer.
Ikeda T; Gion Y; Sakamoto M; Tachibana T; Nishikori A; Nishimura MF; Yoshino T; Sato Y
Mod Pathol; 2020 Dec; 33(12):2437-2448. PubMed ID: 32561847
[TBL] [Abstract] [Full Text] [Related]
16. Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04-16.
Ohki K; Takahashi H; Fukushima T; Nanmoku T; Kusano S; Mori M; Nakazawa Y; Yuza Y; Migita M; Okuno H; Morimoto A; Yoshino H; Kato M; Hayashi Y; Manabe A; Ohara A; Hasegawa D; Inukai T; Tomizawa D; Koh K; Kiyokawa N;
Genes Chromosomes Cancer; 2020 Oct; 59(10):551-561. PubMed ID: 32368831
[TBL] [Abstract] [Full Text] [Related]
17. Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphoma.
Nozaki K; Sugahara H; Ueda S; Ishikawa J; Fuji S; Masaie H; Tada Y; Karasuno T; Iida M; Mitsui H; Kamae T; Saito N; Moriyama Y; Kawakami M; Kato R; Nakae Y; Kida T; Kosugi S; Nakagawa M; Uchida Y; Azenishi Y; Sakaniwa R; Kitamura T; Shibayama H
Leuk Lymphoma; 2020 Sep; 61(9):2113-2121. PubMed ID: 32366194
[TBL] [Abstract] [Full Text] [Related]
18. Proteomic profiling of HTLV-1 carriers and ATL patients reveals sTNFR2 as a novel diagnostic biomarker for acute ATL.
Guerrero CLH; Yamashita Y; Miyara M; Imaizumi N; Kato M; Sakihama S; Hayashi M; Miyagi T; Karimata K; Uchihara J; Ohshiro K; Todoroki J; Nakachi S; Morishima S; Karube K; Tanaka Y; Masuzaki H; Fukushima T
Blood Adv; 2020 Mar; 4(6):1062-1071. PubMed ID: 32196559
[TBL] [Abstract] [Full Text] [Related]
19. [Outcome of children with T cell acute lymphoblastic leukemia treated with Chinese Children Leukemia Group acute lymphoblastic leukemia (CCLG-ALL) 2008 protocol].
Liu XM; Chen XJ; Zou Y; Wang SC; Wang M; Zhang L; Chen YM; Yang WY; Guo Y; Zhu XF
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):761-766. PubMed ID: 31594062
[No Abstract] [Full Text] [Related]
20. High Level of Serum Soluble Interleukin-2 Receptor Is Associated With Poor Survival in Patients With First Relapsed or Refractory Peripheral T-Cell lymphoma, Not Otherwise Specified: A Retrospective Study.
Morita-Fujita M; Katoh D; Shimomura Y; Ishikawa T
Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):e337-e342. PubMed ID: 31053551
[TBL] [Abstract] [Full Text] [Related]
[Next]
